ScoreWhy is Zhejiang Huahai Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 6.87% and Operating profit at -13.17% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 11.11% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 6.87% and Operating profit at -13.17% over the last 5 years
3
With a fall in Net Sales of -11.88%, the company declared Very Negative results in Sep 25
- INTEREST(HY) At CNY 118.65 MM has Grown at 11.09%
- OPERATING CASH FLOW(Y) Lowest at CNY 947.81 MM
- ROCE(HY) Lowest at 5.11%
4
With ROE of 7.38%, it has a expensive valuation with a 3.15 Price to Book Value
- Over the past year, while the stock has generated a return of 1.52%, its profits have fallen by -31.7%
- At the current price, the company has a high dividend yield of 1.2
5
Underperformed the market in the last 1 year
- The stock has generated a return of 1.52% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zhejiang Huahai Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zhejiang Huahai Pharmaceutical Co., Ltd.
15.36%
-0.24
47.46%
China Shanghai Composite
24.7%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.87%
EBIT Growth (5y)
-13.17%
EBIT to Interest (avg)
6.41
Debt to EBITDA (avg)
2.72
Net Debt to Equity (avg)
0.60
Sales to Capital Employed (avg)
0.53
Tax Ratio
22.54%
Dividend Payout Ratio
32.47%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.81%
ROE (avg)
11.11%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
3.15
EV to EBIT
34.63
EV to EBITDA
18.19
EV to Capital Employed
2.32
EV to Sales
4.23
PEG Ratio
NA
Dividend Yield
1.17%
ROCE (Latest)
6.71%
ROE (Latest)
7.38%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-36What is not working for the Company
INTEREST(HY)
At CNY 118.65 MM has Grown at 11.09%
OPERATING CASH FLOW(Y)
Lowest at CNY 947.81 MM
ROCE(HY)
Lowest at 5.11%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.01 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.99 times
NET SALES(Q)
Lowest at CNY 1,892.53 MM
OPERATING PROFIT(Q)
Lowest at CNY -7.27 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -0.38 %
PRE-TAX PROFIT(Q)
Lowest at CNY -13.34 MM
NET PROFIT(Q)
Lowest at CNY 20.01 MM
EPS(Q)
Lowest at CNY -0.02
Here's what is not working for Zhejiang Huahai Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY -13.34 MM has Fallen at -105.11%
over average net sales of the previous four periods of CNY 261.21 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 20.01 MM has Fallen at -89.37%
over average net sales of the previous four periods of CNY 188.19 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 118.65 MM has Grown at 11.09%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 1,892.53 MM has Fallen at -15.28%
over average net sales of the previous four periods of CNY 2,233.87 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 947.81 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 1,892.53 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -7.27 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -0.38 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -13.34 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 20.01 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Lowest at 1.01 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 2.99 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
